Navigation Links
Proove Biosciences Will Be Exhibiting At The 2013 Common Sense Pain Management Conference

Irvine, CA (PRWEB) October 25, 2013

Proove Biosciences, the leading personalized pain medicine laboratory, is excited to be presenting clinical data on how its genetic testing services have been helping doctors better prescribe pain medication at the 2013 Common Sense Pain Management Conference. The event will take place October 25th and 26th at the Renaissance Orlando Airport Hotel, in Orlando, Florida.

This industry CME course, a collaborative partnership between the Florida Medical Association, Florida Academy of Pain Medicine, Florida Society of Interventional Pain Physicians, and Florida Society of Physical Medicine and Rehabilitation, will help attendees and physicians adopt a common sense approach to pain management and controlled substance prescribing practices.

Topics and faculty of the program have been selected to ensure attendees will be better equipped to navigate changing regulations in this complex field. Proove Biosciences Medical Advisory Board member, Andrea Trescot, will present information on how genetic testing for narcotic risk and drug metabolism helps physicians meet new prescribing challenges through practice-based evidence at a dinner event hosted by the program’s organizers on Friday, October 25, 2013.

“We are excited for the opportunity to present our clinical data and research at the Common Sense Pain Management CME course,” stated Proove Biosciences President and Founder, Brian Meshkin. “As the only company who continues to present research on the genetics of pain medicine and as the only company offering proprietary testing services in personalized pain medicine, we look forward to sharing our industry-leading research and services to physicians and pain management professionals.”

About Proove Biosciences
Proove Biosciences is the leading Personalized Pain Medicine laboratory that provides proprietary genetic testing services to help physicians improve outcomes for patients and contain costs for insurers. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve pain medicine selection, dosing, and evaluation of medications they prescribe. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit or call toll free 855-PROOVE-BIO (855-776-6832).

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree
2. Proove Biosciences Continues Its Research Leadership in the Genetics of Pain Medicine at The American Academy of Pain Management’s 24th Annual Meeting
3. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
4. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
5. Sangamo BioSciences Reports Third Quarter 2013 Financial Results
6. Rancho BioSciences will present the tranSMART open source platform at TM Forum’s Digital Disruption 2013, Oct 28-31, San Jose
7. Jeeven BioSciences, Inc. Announces the Release of Its Neuro-XTM Serum-Free and Xeno-Free Tissue Culture Media
8. Castle Biosciences Launches Tissue Repository for Eye Cancer Patients
9. Biotechs Leading the Healthcare Sector - Alliqua, Pacific Biosciences, Oncothyreon, Keryx, Organovo
10. MD Biosciences Publishes the Characterization of a Porcine Model of Post-operative Or Incisional Pain in the European Journal of Pain
11. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division of ... and optimized exclusively for Okuma CNC machining centers at The International Manufacturing Technology ... among several companies with expertise in toolholding, cutting tools, machining dynamics and distribution, ...
(Date:6/22/2016)... SAN DIEGO , June 22, 2016 /PRNewswire/ ... partnership that will allow them to produce up ... (HiPSC) from one lot within one week. These ... their time laboriously preparing cells and spend more ... made possible through a proprietary, high-volume manufacturing process ...
Breaking Biology Technology:
(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
Breaking Biology News(10 mins):